Acutaas Chemicals Limited’s Managing Director has stated confidence in delivering 25% revenue growth in FY27, a forward guidance that arrives on the back of a fourth quarter that already demonstrated the company’s ability to scale profitably — with net profit more than doubling year-on-year even as revenue grew 41%.
The guidance, if delivered, would mean Acutaas adds approximately Rs 550 crore in incremental annualised revenue over FY27, based on the Q4 FY26 run rate of Rs 443.86 crore quarterly income — building on a trajectory that has already seen the company consistently outperform its own historical growth curve.
Why the guidance is credible
The Q4 FY26 numbers provide the foundation for confidence. Revenue grew 41.24% year-on-year to Rs 443.86 crore. Net profit surged 114.11% to Rs 134.28 crore — profit growing at nearly three times the rate of revenue, which is the clearest evidence of operating leverage materialising. EPS doubled year-on-year to Rs 16.09.
Critically, the growth was not paper-thin. Operating cash flow for Q4 jumped to Rs 292.17 crore from Rs 118.34 crore in the same quarter last year — a 147% surge that confirms the earnings are backed by real cash generation. The company’s investing outflows of Rs 265.94 crore signal that capex is being deployed to build the capacity needed to sustain and extend the growth trajectory into FY27 and beyond.
With financing inflows now down sharply to Rs 4.10 crore from Rs 261.12 crore a year ago, the business has effectively become self-financing — a structural shift that gives management the operational freedom to commit to growth targets without being hostage to external capital market conditions.
The 25% target in context
A 25% revenue growth target for FY27 is actually more conservative than the 41% delivered in Q4 FY26 on a year-on-year basis — suggesting the MD is setting a floor rather than an aspirational ceiling. For a specialty chemicals business with strong operating cash generation, completed capex cycles converting to production capacity, and expanding operating margins, 25% revenue growth with continued profit outperformance is a reasonable base case.
The dividend of Rs 2.50 per share declared alongside the Q4 results adds a modest yield signal — confirmation that even through an active investment cycle, the company is generating surplus cash to return to shareholders.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Please consult a qualified financial advisor before making investment decisions.